Selling And Administration Expenses Alterar Data
Acadia Pharmaceuticals USD 111.46M 13.58M 2023-12
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Amarin USD 45.46M 5.5M 2023-09
Amgen USD 1.76B 424M 2023-12
Baxter International USD 832M 47M 2023-12
Cara Therapeutics USD 6.72M 790K 2023-09
Cytokinetics USD 44.11M 4M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Esperion Therapeutics USD 33.24M 719K 2023-09
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Intra Cellular Therapies USD 104.72M 487K 2023-12
Intrexon USD 9.2M 120K 2023-09
Ionis Pharmaceuticals USD 71.01M 1.06M 2023-12
MannKind USD 20.54M 3.44M 2023-12
Minerva Neurosciences USD 2.64M 3.06K 2023-09
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Peregrine Pharmaceuticals USD 6.56M 294K 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Rigel Pharmaceuticals USD 24.86M 1.45M 2023-09
United Therapeutics USD 128.6M 1000K 2023-12
Vanda Pharmaceuticals USD 28.4M 7.7M 2023-06



Halozyme Therapeutics Despesas De Vendas E Administração - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.